Small Interfering RNA for Effective Cancer Therapies

X. Wang, Y. Chen, J. Ren, X. Qu

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Small interfering RNA (siRNA) has become a specific and powerful tool to turn off the expression of target genes, and has turned into a promising tool in molecular medicine. It can be targeted against cancer by several strategies. These include the suppression of overexpressed oncogenes, retarding cell division by interfering with cyclins and related genes or enhancing apoptosis by inhibiting anti-apoptotic genes. RNA interference (RNAi) against multidrug resistance (MDR) genes or chemo/radio-resistance and angiogenesis targets may also provide beneficial cancer treatments. Successful cancer therapy by siRNA in vitro and in vivo provides the enthusiasm for potential therapeutic applications of this technique. Here, we review RNAi in cancer therapy, highlighting recent progress and examining the hurdles that must be overcome before this promising technology is ready for clinical use.

Original languageEnglish (US)
Pages (from-to)114-124
Number of pages11
JournalMini-Reviews in Medicinal Chemistry
Volume11
Issue number2
DOIs
StatePublished - 2011

Fingerprint

Small Interfering RNA
RNA Interference
Neoplasms
Molecular Medicine
MDR Genes
Cyclins
Therapeutics
Radio
Oncogenes
Cell Division
Genes
Apoptosis
Technology
Gene Expression

Keywords

  • Angiogenesis
  • Apoptosis
  • Cancer
  • Cell cycle
  • Multidrug resistance
  • Oncogene
  • Pharmacodynamics
  • Small interfering RNA

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery

Cite this

Small Interfering RNA for Effective Cancer Therapies. / Wang, X.; Chen, Y.; Ren, J.; Qu, X.

In: Mini-Reviews in Medicinal Chemistry, Vol. 11, No. 2, 2011, p. 114-124.

Research output: Contribution to journalArticle

Wang, X. ; Chen, Y. ; Ren, J. ; Qu, X. / Small Interfering RNA for Effective Cancer Therapies. In: Mini-Reviews in Medicinal Chemistry. 2011 ; Vol. 11, No. 2. pp. 114-124.
@article{04dc58461a5c476bb687061752868eef,
title = "Small Interfering RNA for Effective Cancer Therapies",
abstract = "Small interfering RNA (siRNA) has become a specific and powerful tool to turn off the expression of target genes, and has turned into a promising tool in molecular medicine. It can be targeted against cancer by several strategies. These include the suppression of overexpressed oncogenes, retarding cell division by interfering with cyclins and related genes or enhancing apoptosis by inhibiting anti-apoptotic genes. RNA interference (RNAi) against multidrug resistance (MDR) genes or chemo/radio-resistance and angiogenesis targets may also provide beneficial cancer treatments. Successful cancer therapy by siRNA in vitro and in vivo provides the enthusiasm for potential therapeutic applications of this technique. Here, we review RNAi in cancer therapy, highlighting recent progress and examining the hurdles that must be overcome before this promising technology is ready for clinical use.",
keywords = "Angiogenesis, Apoptosis, Cancer, Cell cycle, Multidrug resistance, Oncogene, Pharmacodynamics, Small interfering RNA",
author = "X. Wang and Y. Chen and J. Ren and X. Qu",
year = "2011",
doi = "10.2174/138955711794519528",
language = "English (US)",
volume = "11",
pages = "114--124",
journal = "Mini-Reviews in Medicinal Chemistry",
issn = "1389-5575",
publisher = "Bentham Science Publishers B.V.",
number = "2",

}

TY - JOUR

T1 - Small Interfering RNA for Effective Cancer Therapies

AU - Wang, X.

AU - Chen, Y.

AU - Ren, J.

AU - Qu, X.

PY - 2011

Y1 - 2011

N2 - Small interfering RNA (siRNA) has become a specific and powerful tool to turn off the expression of target genes, and has turned into a promising tool in molecular medicine. It can be targeted against cancer by several strategies. These include the suppression of overexpressed oncogenes, retarding cell division by interfering with cyclins and related genes or enhancing apoptosis by inhibiting anti-apoptotic genes. RNA interference (RNAi) against multidrug resistance (MDR) genes or chemo/radio-resistance and angiogenesis targets may also provide beneficial cancer treatments. Successful cancer therapy by siRNA in vitro and in vivo provides the enthusiasm for potential therapeutic applications of this technique. Here, we review RNAi in cancer therapy, highlighting recent progress and examining the hurdles that must be overcome before this promising technology is ready for clinical use.

AB - Small interfering RNA (siRNA) has become a specific and powerful tool to turn off the expression of target genes, and has turned into a promising tool in molecular medicine. It can be targeted against cancer by several strategies. These include the suppression of overexpressed oncogenes, retarding cell division by interfering with cyclins and related genes or enhancing apoptosis by inhibiting anti-apoptotic genes. RNA interference (RNAi) against multidrug resistance (MDR) genes or chemo/radio-resistance and angiogenesis targets may also provide beneficial cancer treatments. Successful cancer therapy by siRNA in vitro and in vivo provides the enthusiasm for potential therapeutic applications of this technique. Here, we review RNAi in cancer therapy, highlighting recent progress and examining the hurdles that must be overcome before this promising technology is ready for clinical use.

KW - Angiogenesis

KW - Apoptosis

KW - Cancer

KW - Cell cycle

KW - Multidrug resistance

KW - Oncogene

KW - Pharmacodynamics

KW - Small interfering RNA

UR - http://www.scopus.com/inward/record.url?scp=79951715041&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79951715041&partnerID=8YFLogxK

U2 - 10.2174/138955711794519528

DO - 10.2174/138955711794519528

M3 - Article

VL - 11

SP - 114

EP - 124

JO - Mini-Reviews in Medicinal Chemistry

JF - Mini-Reviews in Medicinal Chemistry

SN - 1389-5575

IS - 2

ER -